Please wait a minute...
文章检索
预防医学  2024, Vol. 36 Issue (10): 869-872,877    DOI: 10.19485/j.cnki.issn2096-5087.2024.10.010
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
宝山区居民结直肠癌筛查结果分析
沈方力1, 茅俭英1, 孟杨2, 朱礼明2, 柏红1, 汤德珍2, 刘世友1
1.上海市宝山区疾病预防控制中心慢性病防制二科,上海 201901;
2.上海市宝山区疾病预防控制中心,上海 201901
Analysis of colorectal cancer screening results among residents in Baoshan District
SHEN Fangli1, MAO Jianying1, MENG Yang2, ZHU Liming2, BO Hong1, TANG Dezhen2, LIU Shiyou1
1. Department II of Chronic Disease Control and Prevention, Baoshan District Center for Disease Control and Prevention, Shanghai 201901, China;
2. Baoshan District Center for Disease Control and Prevention, Shanghai 201901, China
全文: PDF(810 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析2013—2021年上海市宝山区居民结直肠癌筛查结果,为完善结直肠癌筛查和防治策略提供依据。方法 选择2013—2021年宝山区50~74岁常住居民为筛查对象,采用危险度评估表和粪便隐血检测进行初筛,危险度评估阳性或粪便隐血检测阳性为初筛阳性,初筛阳性者进行结肠镜检查;分析初筛阳性率、结肠镜检查依从率和结肠镜检查结果。结果 2013—2021年宝山区完成结直肠癌初筛264 907人,初筛阳性65 333人,初筛阳性率为24.66%,其中危险度评估阳性率为12.16%,粪便隐血阳性率为14.64%。14 473人完成结肠镜检查,依从率为22.15%。检出癌前病变1 284例,检出率为8.87%;结直肠癌386例,检出率为2.67%。男性初筛阳性率、结肠镜检查依从率、癌前病变检出率和结直肠癌检出率分别为25.55%、23.12%、11.60%和3.62%,高于女性的24.06%、21.45%、6.74%和1.93%(均P<0.05)。随着年龄增长,初筛阳性率呈上升趋势,结肠镜检查依从率呈下降趋势,癌前病变检出率和结直肠癌检出率呈上升趋势(均P<0.05)。2013—2021年居民初筛阳性率呈下降趋势,结肠镜检查依从率呈上升趋势(均P<0.05)。结论 2013—2021年宝山区结直肠癌癌前病变检出率为8.87%,结直肠癌检出率为2.67%,男性和高龄人群是筛查重点人群,居民结肠镜检查依从性有待提高。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
沈方力
茅俭英
孟杨
朱礼明
柏红
汤德珍
刘世友
关键词 结直肠癌筛查结肠镜检查癌前病变    
AbstractObjective To analyze the results of colorectal cancer screening among residents in Baoshan District, Shanghai Municipality from 2013 to 2021, so as to provide the basis for promoting colorectal cancer screening and prevention. Methods Permanent residents aged 50 to 74 years in Baoshan District from 2013 to 2021 were selected as the screening population. The initial screening was conducted using a risk assessment form and fecal occult blood test. Positive results on either the risk assessment form or fecal occult blood test were considered positive for the initial screening. Participants with positive initial screening results were invited to undergo colonoscopy. The positive rate of the initial screening, colonoscopy compliance rate, and colonoscopy results were analyzed. Results A total of 264 907 individuals underwent the initial colorectal cancer screening in Baoshan District from 2013 to 2021, with 65 333 individuals (24.66%) testing positive. Among them, the positive rate of the risk assessment form was 12.16%, and the positive rate of fecal occult blood test was 14.64%. A total of 14 473 individuals completed colonoscopy, with a compliance rate of 22.15%. A total of 1 284 precancerous lesions were detected, with a detection rate of 8.87%, and 386 cases of colorectal cancer were identified, with a detection rate of 2.67%. The positive rate of the initial screening, colonoscopy compliance rate, precancerous lesion detection rate, and colorectal cancer detection rate were higher in males than in females (25.55% vs. 24.06%, 23.12% vs. 21.45%, 11.60% vs. 6.74%, 3.62% vs. 1.93%, all P<0.05). With increasing age, the positive rate of the initial screening increased, the colonoscopy compliance rate decreased, the precancerous lesion detection rate and colorectal cancer detection rate increased (all P<0.05). From 2013 to 2021, the positive rate of the initial screening among residents showed a downward trend, while the colonoscopy compliance rate showed an upward trend (both P<0.05). Conclusions The detection rate of precancerous lesions in colorectal cancer was 8.87%, and the detection rate of colorectal cancer was 2.67% in Baoshan District from 2013 to 2021. Male and older individuals were the key populations for screening, and the colonoscopy compliance among residents needs to be improved.
Key wordscolorectal cancer    screening    colonoscopy    pericancerous lesions
收稿日期: 2024-04-12      修回日期: 2024-08-12      出版日期: 2024-10-10
中图分类号:  R195.4  
基金资助:上海市宝山区医学重点专科B类项目(BSZK-2023-BZ14)
作者简介: 沈方力,硕士,主管医师,主要从事慢性非传染性疾病防控工作
通信作者: 刘世友,E-mail:370207615@qq.com   
引用本文:   
沈方力, 茅俭英, 孟杨, 朱礼明, 柏红, 汤德珍, 刘世友. 宝山区居民结直肠癌筛查结果分析[J]. 预防医学, 2024, 36(10): 869-872,877.
SHEN Fangli, MAO Jianying, MENG Yang, ZHU Liming, BO Hong, TANG Dezhen, LIU Shiyou. Analysis of colorectal cancer screening results among residents in Baoshan District. Preventive Medicine, 2024, 36(10): 869-872,877.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2024.10.010      或      http://www.zjyfyxzz.com/CN/Y2024/V36/I10/869
[1] 郑荣寿,陈茹,韩冰峰,等.2022年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2024,46(3):221-231.
[2] 寻鲁宁,王冲,沈成凤,等.1990—2019年中国结直肠癌发病趋势分析及预测模型比较[J].中国肿瘤,2023,32(4):279-286.
[3] 顾凯,庞怡,吴春晓,等.2017年上海市恶性肿瘤发病和死亡情况与2002—2017年的变化趋势分析[J].肿瘤,2023,43(4):241-256.
[4] 陈万青,李霓,兰平,等.中国结直肠癌筛查与早诊早治指南(2020,北京)[J].中国肿瘤,2021,30(1):1-28.
[5] 窦剑明,叶景虹,庞怡,等.2013—2015年上海市大肠癌筛查队列病例诊断特征和生存分析[J].肿瘤,2023,43(4):337-346.
[6] 中华医学会肿瘤学分会,国家卫生健康委员会医政司.中国结直肠癌诊疗规范(2023版)[J].协和医学杂志,2023,14(4):706-733.
[7] 和金金,朱陈,潘婷婷,等.定性和定量粪便免疫化学试验筛查结直肠癌效果评价[J].预防医学,2024,36(4):317-321.
[8] 闫蓓,林涛,陈建平,等.基于社区居民大肠癌筛查的高危人群发病风险分级模型构建[J].肿瘤,2022,42(8):570-579.
[9] 罗林飞,李洪,黄紫庆.粪便隐血试验在体检人群中对大肠癌早期筛查的价值[J].现代医药卫生,2024,40(1):43-48.
[10] 张晓,杨琼英,于海波,等.2015—2018年广州市海珠区大肠癌筛查效果分析[J].肿瘤预防与治疗,2021,34(7):637-641.
[11] 袁延楠,杨雷,张希,等.2014—2017年北京市城市结直肠癌早诊早治项目筛查结果分析[J].中国公共卫生,2020,36(1):33-35.
[12] 朱晓云,高霞,王倩,等.2013—2021年上海市金山区社区居民大肠癌筛查结果分析[J].实用肿瘤学杂志,2023,37(2):112-116.
[13] 沈琦,葛英军,刘帅,等.上海郊区某镇大肠癌高危人群结肠镜检查知信行状况及影响因素研究[J].肿瘤预防与治疗,2019,32(8):694-700.
[14] LAIRD S A,RAUDONIS B M.Colorectal cancer screening practices among Texas nurse practitioners and physician assistants[J].Gastroenterol Nurs,2020,43(2):156-163.
[15] 罗卫平,张琳,唐怡菁,等.上海市奉贤区2014—2016年社区居民大肠癌筛查结果分析[J].中国肿瘤,2020,29(2):108-113.
[16] 蒋鸣孝,李剑,黄旭云.上城区结直肠癌筛查结果分析[J].预防医学,2024,36(6):501-505.
[17] MURPHY N,STRICKLER H D,STANCZYK F Z,et al.A prospective evaluation of endogenous sex hormone levels and colorectal cancer risk in postmenopausal women[J].J Natl Cancer Inst,2015,107(10):1-10.
[18] CONTEDUCA V,SANSONNO D,RUSSI S,et al.Precancerous colorectal lesions(Review)[J].Int J Oncol,2013,43(4):973-984.
[19] SCHOLEFIELD J H,MOSS S M,MANGHAM C M,et al.Nottingham trial of faecal occult blood testing for colorectal cancer:a 20-year follow-up[J].Gut,2012,61(7):1036-1040.
[1] 梁薇, 任梦婷, 张文科, 杨琳, 王红雨. 滁州市中小学生脊柱侧弯筛查结果[J]. 预防医学, 2024, 36(7): 607-610.
[2] 蒋鸣孝, 李剑, 黄旭云. 上城区结直肠癌筛查结果分析[J]. 预防医学, 2024, 36(6): 501-505.
[3] 和金金, 朱陈, 潘婷婷, 黄文雯, 蒋秉洁, 余炜燕, 王乐, 吴维妙, 杭栋, 杜灵彬. 定性和定量粪便免疫化学试验筛查结直肠癌效果评价[J]. 预防医学, 2024, 36(4): 317-321.
[4] 胡军路, 冯慧慧, 陈文迪. 献血前健康筛查软件介绍及应用[J]. 预防医学, 2024, 36(4): 362-364.
[5] 陈淑淑, 龚巍巍, 关云琦, 周晓燕, 潘劲, 戴品远, 王浩, 李娜, 俞敏. 1990—2019年浙江省结直肠癌疾病负担和危险因素分析[J]. 预防医学, 2024, 36(3): 203-206.
[6] 高菡璐, 俞晓芳, 吕乐彬, 叶国良, 樊金卿. 多靶点粪便DNA、肠道菌群、癌胚抗原及水果摄入对结直肠癌风险的交互作用研究[J]. 预防医学, 2024, 36(3): 219-223.
[7] 牛贺, 王荣环, 鲍筝. 北京市通州区0~3岁儿童发育筛查结果[J]. 预防医学, 2024, 36(2): 165-168.
[8] 徐亚华, 吴斌. 兰溪市120例HIV抗体筛查阳性样本确证结果分析[J]. 预防医学, 2023, 35(6): 538-540.
[9] 曾龙武, 唐晓鸿, 张素霞, 刘强, 梁朝聪, 唐漫漫. 结直肠癌化疗患者照护人疾病不确定感影响因素分析[J]. 预防医学, 2023, 35(5): 444-447.
[10] 吕乐彬, 樊金卿, 赵王芳, 陆启文, 顾俊娣, 高菡璐. 肠镜检查人群多靶点粪便DNA检测意愿的影响因素分析[J]. 预防医学, 2023, 35(3): 218-223.
[11] 王川, 赵秋玲, 马艳艳, 高倩, 赵月, 罗佳. 2012—2021年朝阳区新生儿遗传代谢病筛查工作质量评价[J]. 预防医学, 2023, 35(11): 1001-1004.
[12] 杨茹莱, 沈亚平, 陈迟, 周莹, 徐艳华, 舒强. 2009—2021年浙江省新生儿遗传代谢病基因型分析[J]. 预防医学, 2022, 34(8): 760-764.
[13] 陈迟, 徐益红, 吴璀璐, 徐艳华, 毛华庆, 杨茹莱. 2009—2021年浙江省新生儿遗传代谢病串联质谱法筛查工作质量评价[J]. 预防医学, 2022, 34(8): 765-770.
[14] 贾娟娟, 林云, 朱国英, 洪霞, 孙炀明, 何海涛, 陈丽艳, 李赟. 嘉兴市中小学生脊柱侧弯调查[J]. 预防医学, 2022, 34(8): 782-787.
[15] 徐艳华, 毛华庆, 徐益红, 杨茹莱. 浙江省新生儿疾病筛查工作质量监测与评价[J]. 预防医学, 2022, 34(8): 848-851.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed